- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00308308
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
October 9, 2014 updated by: Mannkind Corporation
A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 1 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Basal and Prandial Insulin Over a 52-Week Treatment Period and a 4-Week Follow Up
To determine the safety and efficacy of inhaled insulin in the treatment of type 1 diabetes
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
589
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Buenos Aires, Argentina, C1117ABH
- Centro Endocrinologic Tiempo
-
Buenos Aires, Argentina, C1181ACH
- Hospital Italiano de Buenos Aires
-
Buenos Aires, Argentina, C1405CWB
- Hospital Durand /Buenos Aires
-
Buenos Aires, Argentina, C1406FWY
- Hospital Gral De Agudos Dr. Teodoro Alvarez
-
Buenos Aires, Argentina, C1425AGC
- Cons Asoc de Endocrinologia
-
Buenos Aires, Argentina, C1426ABP
- Centro Medico Dra de Salvo
-
Buenos Aires, Argentina
- CIMEL
-
-
Buenos Aires
-
Avellaneda, Buenos Aires, Argentina, B1870ARG
- Hospital Interzonal de Agudos Pedro Fiorito
-
-
-
-
-
Maringa Parana, Brazil, 87020-900
- Universidade Estabual de Maringa
-
Mogi das Cruzes, Brazil, 08780-090
- Nucleo de Medicina Integrada
-
Rio de Janeiro, Brazil, 20211-340
- Instituto Estadual De Diabetes e Endocrinologia Luis Capriglione
-
Rio de Janeiro, Brazil, 22271-100
- CCBR Brasil Centro de Analises e Pesquisas Clínicas LTDA
-
Santos, Brazil, 11045-904
- Hospital Guilherme Alvaro
-
Sao Paulo, Brazil, 01244-030
- CPClin-Centro de Pesquisas Clinicas
-
Sao Paulo, Brazil, 04020-041
- Centro de Diabetes/UNIFESP-EPM
-
Sao Paulo, Brazil, 05302-001
- Blumenau Servicos Medicos S/C Ltda
-
Sao Paulo, Brazil, 05437-010
- Instituto de Pesquisa Clinica e Medicina Avancada
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903
- Hospital de Clinicas de Porto Alegre
-
Porto Alegre, Rio Grande do Sul, Brazil, 90610-000
- Hospital Sao Lucas da PUCRS
-
-
-
-
Ontario
-
Oakville, Ontario, Canada, L6H 3P1
- Lifestyle Metabolism Center
-
Thornhill, Ontario, Canada, L4J 8L7
- Lifestyle Metabolism Center
-
Toronto, Ontario, Canada, M4R 2G4
- Lifestyle Metabolism Center
-
Windsor, Ontario, Canada, N8X 3V6
- Windsor Professional Research
-
-
-
-
-
Santiago, Chile, 1196
- Hospital San José
-
Santiago, Chile
- Hospital Clinico Pontificia Universidad (009)Catolica de Chile
-
Santiago, Chile
- Hospital Padre Alberto Hurtado
-
Santiago, Chile
- Hospital San Borja ArriaranUniversidad de Chile
-
Santiago, Chile
- Instituto de Informacion de Tramiento y Educacion en Salud
-
-
Region Metropolitana
-
Santiago, Region Metropolitana, Chile
- Hospital del Salvador
-
-
-
-
-
Garza Garcia, Mexico, 66260
- Hospital Santa Engracia-CIMA
-
Mexico City, Mexico, 01120
- Centro de Estudios en Diabetes
-
Mexico City, Mexico, 06726
- Hospital General de Mexico Servicio EndocrinologiaJefe Del Servicio
-
Monterrey, Mexico, 64000
- Hospital OCA-MIRC (009)
-
-
Durango
-
Mexico City, Durango, Mexico, 06700
- Instituto Mexicano de Investigacion
-
-
-
-
-
Bialystok, Poland, 15-950
- Oddzial Chorob Wewnetrznych (009 Endokrynologii I Diabetologii Szpitala Wojewodzkiego
-
Lodz, Poland, 90-153
- Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego
-
Warszawa, Poland, 01-911
- NZOZ Diabetologiczna Poradnia Specjalistyczna
-
-
POL
-
Bialystok, POL, Poland, 15-435
- NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny
-
Krakow, POL, Poland, 31 501
- Katedra I Klinika Chorob Metabolicznych Collegium Medicum Uniwersytety Jagiellonskiego
-
Lodz, POL, Poland, 93-338
- Instytut Centrum Zdrowia (009) Matki Polki
-
Pruszkow, POL, Poland, 05 800
- Szpital Kolejowy im Dr w Roeflera(009) Oddzial Gastorenterologii
-
-
-
-
-
Moscow, Russian Federation, 119 048
- City Clinical Hospital # 61
-
Moscow, Russian Federation, 121069
- Russian Scientific Center of Restoration Medicine & Balneology
-
-
RUS
-
Kemerovo, RUS, Russian Federation, 650061
- NHI Kemerovo Regional Clinical Hospital
-
Moscow, RUS, Russian Federation, 105229
- NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense
-
Moscow, RUS, Russian Federation, 111399
- NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70
-
Moscow, RUS, Russian Federation, 115280
- Moscow City Clinical Hospital # 13
-
Moscow, RUS, Russian Federation, 119435
- SEI HPE Moscow Medical Academy IM Sechenov of Roszdrav Clinic of Endocrinology
-
Moscow, RUS, Russian Federation, 125299
- SI Internal Affairs of Moscow- Clinical Hospital
-
Moscow, RUS, Russian Federation, 125315
- RAAMS Endocrinology and Diabetology Department
-
Moscow, RUS, Russian Federation, 127644
- SIH of Moscow City Clinical Hopsital #81Endocrinology and Diabetology
-
St Petersburg, RUS, Russian Federation, 193012
- St Petersburg NHI City Polytclinic #77 City Diabetological Center #4
-
St Petersburg, RUS, Russian Federation, 194291
- Central Medical Sanitary Unit #122
-
St Petersburg, RUS, Russian Federation, 197022
- Pavlov State Medical Univ of St Petersburg
-
St. Petersburg, RUS, Russian Federation, 194354
- St Petersburg NHI Municipal Multi-Speciality Hospital # 2
-
Yaroslavl, RUS, Russian Federation, 150003
- MHI Clinical Hospital for Emergency Care na NV Soloviev
-
Yaroslavl, RUS, Russian Federation, 150023
- MCHI Medical Sanitary Unit of Novo-Yaroslavsky Oil Refining Plant
-
Yaroslavl, RUS, Russian Federation, 150062
- NHI Yaroslavl Regional Clinical Hospital
-
-
-
-
-
Barcelona, Spain, 08003
- Hospital del Mar
-
Madrid, Spain, 28034
- Hospital Ramon y Cajal
-
Sevilla, Spain, 41013
- Complejo Hospitalario Virgen del Rocío
-
Sevilla, Spain, 41071
- Hospital Virgen Macarena (policlinico) 2ª planta Servicio de Endocrinologia y Nutricion
-
-
Andalucia
-
Sevilla, Andalucia, Spain, 41014
- Complejo Hospitalario Nuestra Senora de Valme
-
-
-
-
-
London, United Kingdom, SE1 9RT
- Guy's & St Thomas Hospital
-
Peterborough, United Kingdom, PE7 3JL
- Yaxley Group Practice
-
-
Herts
-
Letchworth, Herts, United Kingdom, SG6 4UB
- Birchwood Surgery
-
Stevenage, Herts, United Kingdom, SG1 4AB
- Lister Hospital
-
-
West Bromwich
-
Lyndon, West Bromwich, United Kingdom, B71 4HJ
- Sandwell General Hospital
-
-
-
-
Alabama
-
Mobile, Alabama, United States, 36608
- Coastal Clinical Research Inc
-
-
Arizona
-
Chandler, Arizona, United States, 85225
- Radiant Research (Phoenix)
-
-
California
-
Chula Vista, California, United States, 91911
- International Clinical Research Network
-
Foothill Ranch, California, United States, 92610
- Family Medical Center
-
Huntington Beach, California, United States, 92648
- Diabetes/Lipid Management and Research Center
-
Inglewood, California, United States, 90301
- South Bay Clinical Research
-
San Diego, California, United States, 92123
- Radiant Research
-
Santa Monica, California, United States, 90404
- Coastal Biomedical Research Inc
-
Tustin, California, United States, 92780
- Diabetes Research Center
-
-
Florida
-
Miami, Florida, United States, 33156
- International Research Associates LLC
-
-
Georgia
-
Atlanta, Georgia, United States, 30308
- Laureate Clinical Research Group
-
Dunwoody, Georgia, United States, 30338
- Atlanta Pharmaceutical Research Center
-
Lawrenceville, Georgia, United States, 30045
- North Atlanta Endocrinology & Diabetes PC
-
Roswell, Georgia, United States, 30076
- Endocrine Research Solutions, Inc.
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- John H Stoger Jr Hospital of Cook County
-
Skokie, Illinois, United States, 60076
- Clintell Inc
-
-
Louisiana
-
Metairie, Louisiana, United States, 70002
- Medical Research of Louisiana
-
New Orleans, Louisiana, United States, 70121
- Oschner Clinic Foundation
-
-
Maryland
-
Towson, Maryland, United States, 21204
- James A Dicke MDPA
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
Livonia, Michigan, United States, 48152
- Michigan Institute of Medicine
-
St Clair Shores, Michigan, United States, 48081
- KMED Research
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Radiant Research Inc (Minneapolis)
-
Minneapolis, Minnesota, United States, 55416
- International Diabetes Center
-
Minneapolis, Minnesota, United States, 55455
- Center for Urologic Clinical Trials University of Minnesota
-
-
Missouri
-
Florissant, Missouri, United States, 63031
- HealthCare Research
-
St Louis, Missouri, United States, 63117
- MedEx Healthcare Research Inc(009)
-
St Peters, Missouri, United States, 63376
- Amin Radparvar's Private Practice
-
-
Montana
-
Billings, Montana, United States, 59101
- Billings Clinic Research Division
-
-
Nebraska
-
Omaha, Nebraska, United States, 68131
- Creighton Diabetes Center
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131
- University of New Mexico HCS
-
-
New York
-
Mineola, New York, United States, 11501
- Winthrop University Hospital
-
New Hyde Park, New York, United States, 11042
- North Shore Diabetes and Endocrine Associates
-
Staten Island, New York, United States, 10301
- University of Physicians Group Endocrine Division
-
-
North Carolina
-
Greenville, North Carolina, United States, 27834
- Endocrine Research - Physician's East PA
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Foundation
-
Dayton, Ohio, United States, 45439
- Providence Health Partners - Center of Clinical Research
-
-
Oregon
-
Portland, Oregon, United States, 97210
- Portland Diabetes & Endocrinology Center
-
Portland, Oregon, United States, 97232
- Legacy Clinical Research
-
Portland, Oregon, United States, 97239
- Covance CRU Inc.
-
-
Pennsylvania
-
Bensalem, Pennsylvania, United States, 19020
- Pennsylvania Research Institute
-
-
South Carolina
-
Williamston, South Carolina, United States, 29697
- Southeastern Research Associates Inc
-
-
Tennessee
-
Bartlett, Tennessee, United States, 38133
- AM Diabetes And Endocrinology Center
-
Memphis, Tennessee, United States, 38119
- The Endocrine Clinic
-
-
Texas
-
Arlington, Texas, United States, 76014
- Israel Hartman MD
-
Dallas, Texas, United States, 75390
- University of Texas Southwestern Medical Center
-
Dallas, Texas, United States, 75231
- Radiant Research Dallas-North
-
Dallas, Texas, United States, 75246
- Baylor Endocrine Center
-
Dallas, Texas, United States, 75230
- Dallas Diabetes & Endocrine Center
-
Friendswood, Texas, United States, 77546
- Spuhler Medical Associates
-
San Antonio, Texas, United States, 78229
- Diabetes & Glandular Disease Research Assoc PA
-
San Antonio, Texas, United States, 78205
- Quality Assurance Research Center (900)
-
San Antonio, Texas, United States, 78229
- Sam Clinical Research Center
-
Seguin, Texas, United States, 78155
- Edward Bali MD PA
-
-
Utah
-
Salt Lake City, Utah, United States, 84107
- Radiant Research Salt Lake City
-
Salt Lake City, Utah, United States, 84107
- Salt Lake Research
-
-
Virginia
-
Virginia Beach, Virginia, United States, 23462
- Sentara Medical Group
-
-
Washington
-
Federal Way, Washington, United States, 98003
- Larry D Stonesifer MD Inc PS
-
Tacoma, Washington, United States, 98405
- Cedar Research
-
Tacoma, Washington, United States, 98405
- Liberty Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of type 1 diabetes for at least 1 year
- Nonsmokers for prior 6 months
- BMI less than or equal to 35kg/m2
- HbA1c > or = 7% and < or = 11%
- Serum creatinine < or = 1.8 mg/dL in female subjects and < or = 2.0 mg/dL in male subjects
- FEV1 > or = 70% of predicted, DLco > or = 70% , TLC > or = 80% predicted
- Maintenance of a treatment regimen of insulin less than or equal to 1.4 iu/kg/day
- Urine cotinine < or = 100 ng/mL
Exclusion Criteria:
- History of chronic obstructive pulmonary disease, asthma, any other clinically significant pulmonary disease confirmed by documented history, pulmonary function testing or radiologic findings
- Evidence of severe complications of diabetes
- Aminotransferase and/or alanine aminotransferase > than 3 times the upper limit of normal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Technosphere Insulin
|
Inhalation, 15U/30U
|
Active Comparator: 2
Rapid-acting analogue insulin plus basal insulin glargine
|
sc injectable insulin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Compare the Mean Change From Baseline to Week 52 in HbA1c
Time Frame: Baseline to Week 52
|
Baseline to Week 52
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline in Weight to Week 52
Time Frame: Baseline to Week 52
|
Change from baseline in weight at Week 52
|
Baseline to Week 52
|
Change From Baseline in Fasting Plasma Glucose to Week 52
Time Frame: Baseline to Week 52
|
Change from baseline in fasting plasma glucose at Week 52
|
Baseline to Week 52
|
Number of Subjects Achieving Week 52 HbA1c Levels Less Than or Equal to 7.0%
Time Frame: Baseline to Week 52
|
Number of subjects achieving week 52 HbA1c levels less than or equal to 7.0%
|
Baseline to Week 52
|
Incidence of Total Hypoglycemia
Time Frame: Baseline to Week 52
|
Defined as hypoglycemic symptoms that are relieved with carbohydrate intake or blood glucose measurement <= 63 mg/dL, regardless of symptoms.
|
Baseline to Week 52
|
Incidence of Severe Hypoglycemia
Time Frame: Baseline to Week 52
|
Severe hypoglycemia occurs when all 3 of the following occur simultaneously:
|
Baseline to Week 52
|
Total Hypoglycemia Event Rate
Time Frame: Baseline to Week 52
|
Number of Hypoglycemic Events/Total Subject Exposure Time (in months)
|
Baseline to Week 52
|
Severe Hypoglycemia Event Rate
Time Frame: Baseline to Week 52
|
Number of Severe Hypoglycemic Events/Total Subject Exposure Time (in months)
|
Baseline to Week 52
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2006
Primary Completion (Actual)
July 1, 2008
Study Completion (Actual)
August 1, 2008
Study Registration Dates
First Submitted
March 27, 2006
First Submitted That Met QC Criteria
March 27, 2006
First Posted (Estimate)
March 29, 2006
Study Record Updates
Last Update Posted (Estimate)
October 16, 2014
Last Update Submitted That Met QC Criteria
October 9, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MKC-TI-009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes, Type I
-
Hadassah Medical OrganizationOramed Pharmaceutical Inc.CompletedBrittle Type I Diabetes MellitusIsrael
-
Nemours Children's ClinicThrasher Research FundCompleted
-
HealthPartners InstituteInternational Diabetes Center at Park Nicollet; Park Nicollet Foundation; Melrose...TerminatedEating Disorder | Type I Diabetes Mellitus Without ComplicationUnited States
-
Nationwide Children's HospitalTerminated
-
Eunice Kennedy Shriver National Institute of Child...CompletedType I DiabetesUnited States
-
Ohio State UniversityNatreon, Inc.Completed
-
National Institute of Diabetes and Digestive and...CompletedType I DiabetesUnited States
-
Hompesch, Marcus, M.D.Profil Institute for Clinical Research, Inc.Unknown
-
Diatranz Otsuka LimitedCompleted
-
Migal Galilee Research InstituteZiv Medical CenterUnknownType I DiabetesIsrael
Clinical Trials on Technosphere Insulin
-
Mannkind CorporationCompleted
-
Mannkind CorporationCompletedType 2 Diabetes Mellitus
-
Mannkind CorporationCompleted
-
Mannkind CorporationCompletedType 2 DiabetesUnited States, Russian Federation, Brazil, Ukraine
-
Mannkind CorporationCompletedHealthy VolunteersUnited States
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2United States, Brazil, Spain, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, Ukraine, Czech Republic
-
Mannkind CorporationCompleted
-
Mannkind CorporationCompletedType 1 Diabetes MellitusUnited States, Brazil, Russian Federation, Ukraine
-
Mannkind CorporationCompletedDiabetes Mellitus | Upper Respiratory InfectionUnited States, Russian Federation, Canada
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2Germany